Wiley Blackwell

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Brennan
    Brennan
  3. Motzer
    Motzer
  4. Shah
    Shah
  5. Danishefsky
    Danishefsky
  6. Russo
    Russo
  7. Shaha
    Shaha
  8. Vickers
    Vickers
  9. Eastham
    Eastham
  10. Mulhall
    Mulhall

Groups

  1. Department of Medicine (1520)
  2. Surgery (1224)
  3. Solid Tumor Oncology Division (883)
  4. Survivorship Research (806)
  5. GSK Faculty (664)
  6. Sloan Kettering Institute Faculty (622)
  7. Population Sciences Research Program (614)
  8. Department of Pathology and Laboratory Medicine (533)
  9. Epidemiology and Biostatistics (484)
  10. Center for Hematologic Malignancies (432)
Search Within
Formats
  1. Journal Article (3486)
  2. Meeting Abstract (680)
  3. Review (197)
  4. Conference Paper (94)
  5. Book Section (91)
  6. Editorial (90)
  7. Research Letter (34)
  8. Correspondence (25)
  9. Guidelines (23)
  10. Miscellaneous (6)
  11. Book Whole (3)
Groups
  1. Department of Medicine (1520)
  2. Surgery (1224)
  3. Solid Tumor Oncology Division (883)
  4. Survivorship Research (806)
  5. GSK Faculty (664)
  6. Sloan Kettering Institute Faculty (622)

More Groups

People
  1. Harry Herr (91)
  2. Murray Brennan (86)
  3. Robert Motzer (86)
  4. Jatin Shah (77)
  5. Samuel Danishefsky (74)
  6. Ashok Shaha (71)

More People

Years
  1. 2025 (80)
  2. 2024 (195)
  3. 2023 (264)
  4. 2022 (187)
  5. 2021 (221)
  6. 2020 (183)

More Years

Publications
  1. Cancer (1449)
  2. Journal of Surgical Oncology (368)
  3. BJU International (332)
  4. Hematological Oncology (199)
  5. Histopathology (151)
  6. EMBO Journal (131)

More Publications

Results (4729)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: Update on a COVID era ILROG collaborative report
    Meeting Abstract

    Yang, J.; Gunther, J.; Hajj, C.; Ng, A.; Brady, J. L.; Cheng, S.; Levis, M.; Qi, S.; Mikhaeel, N. G.; Ricardi, U.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 1 trial of KT‐333, a STAT3 degrader, in patients with relapsed or refractory lymphomas, large granular lymphocytic leukemia and solid tumors
    Meeting Abstract

    Smith, S.; Olszewski, A.; Starodub, A. N.; Stevens, D. A.; Feldman, T.; Porcu, P.; Epstein-Peterson, Z.; Huen, A.; Pinter‐Brown, L.; Mattour, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Functional precision oncology for follicular lymphoma with patient‐derived xenograft in avian embryos
    Meeting Abstract

    Zala, M.; Lipinski, B.; Costechareyre, C.; Jarrosson, L.; Teinturier, R.; Julia, E.; Verney, A.; Guitton, J.; Traverse‐Glehen, A.; Bachy, E.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Multicenter experience with radiotherapy for relapse after chimeric antigen receptor T cell therapy in non‐Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H.; Figura, N.; Ladbury, C.; Keit, E. R.; Chew, J.; Fregonese, B.; Silverman, E. A.; Hajj, C.; Shah, G.; Kambhampati, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Drug‐resistance mutations in BTK occur in distinct enzymatic classes and are overcome by BTK degradation
    Meeting Abstract

    Montoya, S.; Bourcie, J.; Sondhi, A.; Jahn, J.; Alencar, A.; Abdel-Wahab, O.; Taylor, J.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • MicroRNAs regulate novel signaling pathways targetable by PI3K, MEK, BCL6 and EZH2 inhibitors in ibrutinib resistance mantle cell lymphoma
    Meeting Abstract

    Kersy, O.; Salmon‐Divon, M.; Gomes da Silva, M.; Moita, F.; Cabecadas, J.; Trněný, M.; Basood, M.; Abdel-Wahab, O.; Klener, P.; Shpilberg, O.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • 3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant
    Meeting Abstract

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19‐targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B‐cell lymphoma
    Meeting Abstract

    Palomba, M. L.; Riviere, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E. R.; Liotta, K.; Li, J.; Sellner, L.; Sadelain, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies
    Meeting Abstract

    Cederquist, G.; Hubbeling, H.; Tringale, K.; Shah, G.; Alarcon Tomas, A.; Shouval, R.; Hajj, C.; Fregonese, B.; Lee, J.; Dahi, P. B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Long term outcome of peripheral T cell lymphomas: 10y follow‐up analysis of the International Prospective T Cell Project Network
    Meeting Abstract

    Civallero, M.; Advani, R.; Horwitz, S.; Manni, M.; Cabrera, M. E.; Vose, J.; Spina, M.; Hits, F.; Nagler, A.; Montoto, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save